###begin article-title 0
###xml 37 42 <span type="species:ncbi:9606">Human</span>
###xml 65 70 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion
###end article-title 0
###begin p 1
Conceived and designed the experiments: RKG SH TS GJT. Performed the experiments: RKG SH TS. Analyzed the data: RKG SH TS GJT. Contributed reagents/materials/analysis tools: RKG SH TS EJV DP GJT. Wrote the paper: RKG SH TS GJT.
###end p 1
###begin p 2
###xml 129 134 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 174 179 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 295 300 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 538 543 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 598 603 <span type="species:ncbi:9606">human</span>
###xml 652 657 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1031 1036 <span type="species:ncbi:9606">human</span>
###xml 1120 1125 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1437 1442 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1510 1515 <span type="species:ncbi:9606">human</span>
The recently identified restriction factor tetherin/BST-2/CD317 is an interferon-inducible trans-membrane protein that restricts HIV-1 particle release in the absence of the HIV-1 countermeasure viral protein U (Vpu). It is known that Tantalus monkey CV1 cells can be rendered non-permissive to HIV-1 release upon stimulation with type 1 interferon, despite the presence of Vpu, suggesting species-specific sensitivity of tetherin proteins to viral countermeasures such as Vpu. Here we demonstrate that Tantalus monkey tetherin restricts HIV-1 by nearly two orders of magnitude, but in contrast to human tetherin the Tantalus protein is insensitive to HIV-1 Vpu. We have investigated tetherin's sensitivity to Vpu using positive selection analyses, seeking evidence for evolutionary conflict between tetherin and viral countermeasures. We provide evidence that tetherin has undergone positive selection during primate evolution. Mutation of a single amino acid (showing evidence of positive selection) in the trans-membrane cap of human tetherin to that in Tantalus monkey (T45I) substantially impacts on sensitivity to HIV-1 Vpu, but not on antiviral activity. Finally, we provide evidence that cellular steady state levels of tetherin are substantially reduced by Vpu, and that the T45I mutation abrogates this effect. This study provides evidence that tetherin is important in protecting mammals against viral infection, and that the HIV-1 Vpu-mediated countermeasure is specifically adapted to act against human tetherin. It also emphasizes the power of selection analyses to illuminate the molecular details of host-virus interactions. This work suggests that tetherin binding agents might protect it from viral encoded countermeasures and thus make powerful antivirals.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 354 359 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 476 481 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 583 588 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
###xml 997 1002 <span type="species:ncbi:9606">human</span>
###xml 1029 1034 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Pathogenic viruses have been infecting mammals throughout their evolution, exerting selective pressure to evolve systems to limit or eliminate these parasites. For example, intracellular proteins called restriction factors specifically restrict viral infection by targeting important viral processes. The restriction factor tetherin tethers newly formed HIV-1 virions to the surface of infected cells, preventing egress and further infection. In order to counteract tetherin, HIV-1 encodes a membrane-associated protein called Vpu that abrogates tetherin activity. Here we show that HIV-1 Vpu is inactive against tetherin from Tantalus monkeys and that this is due to a single amino acid that differs between human and tantalus monkey tetherin sequences. Evidence for positive selection at this position suggests that viral infections have provided the Darwinian selective pressure leading to this change. We also show that Vpu expression leads to a loss of tetherin protein in cells. Mutation of human tetherin protects it from HIV-1 Vpu activity, allowing functional protein expression and restriction of viral release. This study underlines the utility of selection analyses to reveal determinants of antiviral specificity and is strong evidence for the host-virus arms race described by the Red Queen hypothesis.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 489 492 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-VanHeuverswyn1">[1]</xref>
###xml 664 667 660 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Stremlau1">[2]</xref>
###xml 700 703 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Sheehy1">[3]</xref>
###xml 704 707 700 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Huthoff1">[4]</xref>
###xml 732 735 728 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil1">[5]</xref>
###xml 736 739 732 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-VanDamme1">[6]</xref>
###xml 983 986 979 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil1">[5]</xref>
###xml 987 990 983 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil3">[8]</xref>
###xml 1093 1096 1089 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Kupzig1">[9]</xref>
###xml 1202 1206 1198 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Ohtomo1">[10]</xref>
###xml 1304 1308 1300 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Sakuma1">[11]</xref>
###xml 1526 1529 1522 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil1">[5]</xref>
###xml 1530 1533 1526 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-VanDamme1">[6]</xref>
###xml 1655 1659 1651 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Strebel1">[12]</xref>
###xml 419 424 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 447 453 <span type="species:ncbi:9606">humans</span>
###xml 455 466 <span type="species:ncbi:9598">chimpanzees</span>
###xml 480 488 <span type="species:ncbi:499232|species:ncbi:9593">gorillas</span>
###xml 1413 1418 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1451 1456 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Retroviruses are obligate cellular parasites and as such rely on a wide variety of host proteins and pathways to complete their lifecycle. Moreover, they are subject to a variety of cellular antiviral activities that they must either overcome or avoid in order to successfully infect a cell. Together these positive and negative acting host factors combine to give primate lentiviruses narrow host ranges. For example, HIV-1 can only replicate in humans, chimpanzees and possibly gorillas [1]. A particular class of interferon inducible, cellular, innate immune factors, active against retroviruses, is referred to as restriction factors. These include TRIM5alpha [2], APOBEC3G (A3G), APOBEC3F (A3F) [3],[4] and tetherin/BST2/CD317 [5],[6]. Tetherin has been demonstrated to tether nascent retroviral virions to the plasma membrane, preventing their release from the infected cell. Instead, they are recruited back into the cell in endosomes for eventual destruction in the lysosome [5]-[8]. Tetherin has predicted trans-membrane and coiled coil regions as well as a predicted GPI anchor site [9]. It has also been shown to exist as a dimer and is glycosylated at two sites in its extracellular domain [10] although glycosylation does not appear to be important for restriction of Lassa or Marburg virus [11]. In a striking parallel to the antagonistic relationship between the antiviral A3G/F proteins and their HIV-1 encoded countermeasure Vif, the HIV-1 viral protein U (Vpu) counteracts the antiviral activity of tetherin [5],[6]. Vpu is a 16 kilodalton oligomeric type 1 trans-membrane protein encoded by an alternative reading frame in the env gene [12].
###end p 6
###begin p 7
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-VanValen1">[13]</xref>
###xml 681 685 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Sawyer1">[14]</xref>
###xml 686 690 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Sawyer2">[15]</xref>
###xml 1069 1074 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1148 1153 <span type="species:ncbi:9606">human</span>
###xml 1176 1181 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The antagonistic relationship between innate antiviral proteins, and the viruses that they restrict, is an excellent example of the Red Queen hypothesis [13]. This hypothesis proposes that pathogens and their hosts are locked in evolutionary conflict, each subject to selective pressure from the other to gain the advantage. This evolutionary arms race leads to alternate change followed by advantage and an overall maintenance of the relationship between host and pathogen. In support of this hypothesis, proteins such as TRIM5alpha and APOBEC3G have been shown to be under strong positive selection pressure throughout primate evolution, presumably from viruses that they target [14],[15]. Indeed, the study of adaptive selection and the analysis of species-specific restriction have illuminated details of the evolution of antiviral proteins as they change in response to rapidly evolving pathogens. Here we provide evidence for positive selection of tetherin and demonstrate that positively selected residues impact on sensitivity to Vpu but not on tetherin's anti HIV-1 activity. Furthermore, we show that mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated cellular depletion.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 73 78 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tantalus monkey tetherin restricts HIV-1 release but is not sensitive to HIV-1 Vpu
###end title 9
###begin p 10
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 894 903 894 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1A</xref>
###xml 1082 1085 1082 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil1">[5]</xref>
###xml 1086 1089 1086 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-VanDamme1">[6]</xref>
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 156 161 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 213 218 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 499 504 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 599 604 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 676 681 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 753 758 <span type="species:ncbi:9606">human</span>
###xml 801 806 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 846 851 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 875 880 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 947 952 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 956 961 <span type="species:ncbi:9606">human</span>
###xml 991 996 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To measure tetherin antiviral activity and its abrogation by the viral Vpu protein, we utilised HIV-1 YFP encoding vectors. Transfection of 293T cells with HIV-1 vector plasmids leads to production and release of HIV-1 virions containing a YFP encoding genome. The efficiency of virion release can then be measured by titration of the 293T supernatant on permissive target cells. Expression of viral proteins and release of virions from transfected cells was also assayed by western blot, detecting HIV-1 capsid in extracts from the transfected cells and the supernatant respectively. Expression of HIV-1 vector plasmids in the absence of tetherin or Vpu led to production of HIV-1 YFP with a titer of around 5x107 infectious units/ml. Co-expression of human tetherin significantly reduced infectious HIV-1 vector production and co-expression of HIV-1 Vpu completely rescued HIV-1 YFP release (Figure 1A). These data, demonstrating restriction of HIV-1 by human tetherin, and the ability of HIV-1 Vpu to act as countermeasure to tetherin, are concordant with described observations [5],[6].
###end p 10
###begin title 11
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 73 78 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tantalus monkey tetherin restricts HIV-1 release but is not sensitive to HIV-1 Vpu.
###end title 11
###begin p 12
###xml 902 911 902 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1A</xref>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 94 99 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 361 366 <span type="species:ncbi:9606">Human</span>
###xml 384 389 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 475 480 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 521 526 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 557 562 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 668 673 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 726 731 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 933 938 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1203 1208 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1264 1269 <span type="species:ncbi:9606">human</span>
###xml 1354 1359 <span type="species:ncbi:9606">human</span>
###xml 1403 1408 <span type="species:ncbi:9606">human</span>
(A) 293T cells were left untransfected (arrow) or co-transfected with HIV-1 Gag-pol (250 ng), HIV-1 YFP vector (375 ng), and VSV-G (250 ng) encoding plasmids alone (C) or along with plasmids encoding for human (HuTHN) or Tantalus monkey (TanTHN) tetherin (100 ng). Virus containing supernatants were titered on 293T cells and infectious titers were calculated. Human tetherin reduces HIV-1 release by 2 orders of magnitude and this is completely overcome by co-expression of HIV-1 Vpu. Tantalus monkey tetherin restricts HIV-1 release and is insensitive to HIV-1 Vpu. Error bars represent standard deviation of mean titers calculated from two independent experiments. HIV-1 Gag p24 and p55 bands are shown. (B) Measurement of HIV-1 p24 in the supernatant of transfected 293T cells by western blot using an anti p24 antibody demonstrates that p24 levels reflect infectious titers of the released virus (Figure 1A). (C) Measurement of HIV-1 Gag levels in extracts from transfected 293T cells demonstrates that tetherin expression does not reduce viral protein expression. (D) Cell extract blots in C were stripped and re-probed for beta actin as a loading control. (E) 293T cells were co-transfected with HIV-1 vector plasmids, 200 ng Vpu plasmid and a titration of human tetherin plasmid (E) or Tantalus monkey tetherin plasmid (F) as shown. Titration of human tetherin demonstrates that Vpu counteracts human tetherin at high and low tetherin doses whereas titration of Tantalus monkey tetherin demonstrates that Vpu does not counteract Tantalus tetherin even when tetherin doses are low.
###end p 12
###begin p 13
###xml 77 80 77 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil3">[8]</xref>
###xml 533 542 533 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1A</xref>
###xml 646 649 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil3">[8]</xref>
###xml 1067 1076 1067 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1A</xref>
###xml 1135 1144 1135 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1B</xref>
###xml 1216 1225 1216 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1C</xref>
###xml 1274 1283 1271 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1D</xref>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 150 155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 283 288 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 386 391 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 481 486 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 582 587 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 617 622 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 720 725 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 836 841 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tantalus monkey CV1 cells are able to release HIV-1 in a Vpu insensitive way [8]. Furthermore, after interferon treatment these cells support reduced HIV-1 release. We hypothesised that this might be due to interferon induced expression of a tetherin protein that was insensitive to HIV-1 Vpu. To test this we cloned the Tantalus monkey tetherin from CV1 cells and co-expressed it with HIV-1 vector plasmids as above. Indeed, expression of the Tantalus tetherin protein restricted HIV-1 YFP release, by almost 2 orders of magnitude (Figure 1A). Importantly, and in concordance with HIV-1 Vpu's inability to stimulate HIV-1 release from CV1 cells [8], restriction by Tantalus tetherin was insensitive to co-expression of HIV-1 Vpu. This observation suggests that the Vpu mediated tetherin countermeasure is species-specific and that the HIV-1 Vpu protein cannot counteract the antiviral activity of the Tantalus tetherin protein. Measurement of Gag levels in the supernatant and transfected cells by western blot with a p24 CA antibody demonstrated that viral titers (Figure 1A) reflect the amount of p24 released into the supernatant (Figure 1B) and that tetherin expression did not impact on Gag expression levels (Figure 1C). beta actin was measured as a loading control (Figure 1D). We note that there is evidence for increased levels of protease cleaved Gag in the cell extracts in the presence of tetherin restriction, consistent with the notion that maturing particles are tethered to the surface of the restrictive cells.
###end p 13
###begin p 14
###xml 211 220 211 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1E</xref>
###xml 245 254 245 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1F</xref>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 462 467 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 600 605 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
It is possible that Tantalus tetherin is insensitive to Vpu because it is expressed more efficiently than the human protein and it therefore saturates the HIV-1 Vpu protein. To test this we titrated both human (Figure 1E) and Tantalus tetherin (Figure 1F) against a fixed dose of Vpu and measured the titer of the released virus. In fact human tetherin was counteracted by Vpu at high or low doses whereas Tantalus tetherin was not significantly counteracted by HIV-1 Vpu, even when the dose of tetherin was low. These data are consistent with the notion that Tantalus tetherin is insensitive to the HIV-1 encoded tetherin countermeasure Vpu.
###end p 14
###begin title 15
Selection analyses reveal positively selected tetherin residues in the primate lineage
###end title 15
###begin p 16
###xml 390 394 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Sawyer1">[14]</xref>
###xml 395 399 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Wilson1">[17]</xref>
###xml 528 537 524 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g002">Figure 2A</xref>
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species specificity of the tetherin/Vpu interaction is reminiscent of the species specificity of HIV-1 Vif activity against primate APOBEC3G proteins, as well as the species specificity of TRIM5alpha against retroviruses. In both of these examples the determinants of specificity can be revealed by analysis of positive selection in the species-specific variants of each restriction factor [14]-[17]. We therefore gathered tetherin sequences from a variety of primates and aligned them to the Tantalus monkey tetherin sequence (Figure 2A). The alignment revealed that primate tetherin sequences are divergent (mean pairwise genetic difference of 0.116 nucleotide substitutions per site, standard deviation 0.085 substitutions/sites), yet 93 out of 180 amino acid sites are conserved along the primate alignment, excluding positions with gaps.
###end p 16
###begin title 17
Selection analyses reveal positively selected tetherin residues in the primate lineage.
###end title 17
###begin p 18
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-McGuffin1">[53]</xref>
###xml 104 113 <span type="species:ncbi:9601">Orangutan</span>
###xml 138 148 <span type="species:ncbi:9598">Chimpanzee</span>
###xml 180 193 <span type="species:ncbi:9534">Vervet monkey</span>
###xml 270 287 <span type="species:ncbi:9541">cynomolgus monkey</span>
###xml 314 328 <span type="species:ncbi:9544">Rhesus macaque</span>
###xml 337 355 <span type="species:ncbi:9483">Callithrix jacchus</span>
###xml 985 990 <span type="species:ncbi:9606">human</span>
###xml 1041 1046 <span type="species:ncbi:9606">Human</span>
(A) Nucleotide alignment of nine primate tetherin sequences. HoSa (Homo Sapiens), Popy (Pongo Pygmaeus (Orangutan)) Patr (Pan Trolodytes (Chimpanzee)), Tan (Tantalus monkey), Ver (Vervet monkey), Mane (Macaque Nemestrina (pigtailed macaque)), Mafa (Macaque Fasicularis (cynomolgus monkey)), Mamu (Macaque Mulatta (Rhesus macaque)) Caja (Callithrix jacchus (white tufted ear marmoset). Codon positions under positive selection are indicated by shaded boxes. Secondary structure (SS) was predicted by PSIPRED [53] and is symbolised as (+) cytoplasmic domain; (I) trans-membrane domain inner cap; (X) trans-membrane domain alpha helix; (O) trans-membrane domain outer cap; (-) extra-cellular domain. (B) Predicted structure of the trans-membrane helix performed using helical wheel projection () suggests that residues 26, 30, and 36 are on the same side of the protein. Closed circles indicate positively selected amino acids, dashed circles indicate residues that are different between human and Tantalus monkey, but not positively selected. Human amino acids are shown in black and Tantalus monkey in grey italic.
###end p 18
###begin p 19
###xml 102 103 102 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 101 103 101 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 319 320 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub>/d<sub>S</sub></italic>
###xml 419 420 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 422 423 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub>/d<sub>S</sub></italic>
###xml 672 673 672 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 675 676 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub>/d<sub>S</sub></italic>
###xml 817 818 817 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 820 821 820 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 816 821 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub>/d<sub>S</sub></italic>
###xml 1367 1376 1367 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g002">Figure 2A</xref>
###xml 1378 1385 1378 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000443-t001">Table 1</xref>
###xml 1572 1581 1572 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g002">Figure 2B</xref>
###xml 1719 1726 1719 1726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000443-t001">Table 1</xref>
###xml 1278 1283 <span type="species:ncbi:9606">human</span>
We examined the alignment of primate tetherin sequences for evidence of heterogeneity of synonymous (dN) and non-synonymous (dS) substitution rates, indicative of adaptive selection. An excess of non-synonymous substitutions, which lead to protein sequence change, compared to synonymous substitutions, which do not, (dN/dS>1) is traditionally regarded as indicative of positive (or adaptive) selection. Conversely, a dN/dS<1 suggests negative (or purifying) selection. Although the average rates of synonymous changes exceeded rates of non-synonymous changes across the sequence alignment, reflecting a predominance of purifying selection on the tetherin genes (average dN/dS = 0.93; 95% Confidence Intervals = 0.76; 1.11), evidence for positive selection was found when maximum likelihood models allowing variable dN/dS ratios among sites were applied to the data. The model allowing sites to evolve under positive selection had a significantly better fit to the data than the model assuming no positive selection (likelihood ratio test with 2 degrees of freedom; p = 0.018). Furthermore, analyses of codon-specific positive selection in the primate lineage revealed fifteen residues potentially under adaptive selection, five of which, positions 24, 26, 30, 36 and 45 in the human tetherin sequence, were found in or bordering the predicted trans-membrane domain (Figure 2A, Table 1). We note that the three selected trans-membrane residues present in the central helix are predicted to be on the same side of the helix and therefore in close proximity to one another (Figure 2B). Additional sites showing evidence of positive selection were found in the predicted cytoplasmic and C terminal extra-cellular domains (Table 1).
###end p 19
###begin title 20
Positive selection in the tetherin gene.
###end title 20
###begin p 21
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 36 38 36 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 60 62 60 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
Codon-specific rates of synonymous (dS) and non-synonymous (dN) nucleotide substitutions were estimated by Random Effect Likelihood methods under the MG94xHKY85 model of evolution. The Bayesian posterior probability for positive selection is given for each codon position. A Bayes factor of greater than 20 at a given site was considered to be strong support for positive selection.
###end p 21
###begin p 22
###xml 33 38 <span type="species:ncbi:9606">human</span>
Codon positions according to the human tetherin sequence (NM004335). Codons in the trans-membrane region are indicated in bold.
###end p 22
###begin p 23
Posterior probability for positive selection (dN>dS) at the site.
###end p 23
###begin title 24
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The positively selected tetherin trans-membrane region residues impact on sensitivity to HIV-1 Vpu
###end title 24
###begin p 25
###xml 470 473 470 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil2">[7]</xref>
###xml 592 595 592 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-VanDamme1">[6]</xref>
###xml 874 882 874 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g002">Figure 2</xref>
###xml 1235 1244 1235 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3A</xref>
###xml 1457 1469 1457 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3A&#8211;3D</xref>
###xml 1576 1585 1576 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3A</xref>
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 669 674 <span type="species:ncbi:9606">human</span>
###xml 764 769 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 918 923 <span type="species:ncbi:9606">human</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
###xml 1073 1078 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1098 1103 <span type="species:ncbi:9606">human</span>
###xml 1124 1129 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1213 1218 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1263 1268 <span type="species:ncbi:9606">human</span>
###xml 1332 1337 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1394 1399 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1561 1566 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1768 1773 <span type="species:ncbi:9606">human</span>
###xml 2012 2017 <span type="species:ncbi:9606">human</span>
###xml 2042 2047 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2097 2102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Knowing that HIV-1 Vpu counteracts human tetherin we hypothesised that the differences between primate tetherin sequences might be due to selective pressure from pathogenic retroviruses encoding tetherin countermeasures. We focused on the trans-membrane domain as a likely site for Vpu interaction because both tetherin and Vpu are integral membrane proteins and replacing the Vpu trans-membrane domain with that from CD8 causes mislocalisation and loss of Vpu activity [7]. Furthermore, a non-functional Vpu with a scrambled trans-membrane region co-localised less extensively with tetherin [6]. We hypothesised that changing the trans-membrane region residues in the human tetherin protein to those in the Tantalus monkey protein should impact on sensitivity to HIV-1 Vpu. Of positions 24, 26, 30, 36 and 45, which are in or bordering the predicted trans-membrane region (Figure 2), position 24 is conserved between human and Tantalus monkey. We therefore made a human quadruple tetherin mutant I26V, V30G, I36L, T45I and tested its antiviral activity and sensitivity to HIV-1 Vpu. The wild-type human tetherin suppressed HIV-1 release reducing infectious titer by 78 fold and release was completely rescued by HIV-1 Vpu expression (Figure 3A). Conversely, the human tetherin quadruple mutant (Quad) was able to potently suppress HIV-1 release but was only weakly rescued by co-expression of HIV-1 Vpu, 4 fold vs 78 fold rescue for the wild-type protein (Figure 3A-3D). Importantly, the mutations did not significantly reduce tetherin's antiviral activity on HIV-1 release (Figure 3A, black bars). In order to examine the contribution of each selected residue to Vpu sensitivity we tested single mutants for antiviral activity and Vpu sensitivity. In fact, mutating human residue 30 (V30G) moderately reduced its Vpu sensitivity (from 78 to 15 fold) whereas mutating residue 45 (T45I) had a similar impact as mutating all 4 residues (5 fold versus 4 fold rescue on Vpu expression). Remarkably, it appears that human tetherin can escape the HIV-1 encoded tetherin countermeasure Vpu and restrict HIV-1 if a single tetherin amino acid is changed to reflect the Tantalus monkey sequence. Indeed, the evidence for positive selection suggests that the tetherin gene has been under pressure to change at this position during primate evolution.
###end p 25
###begin title 26
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The positively selected tetherin trans-membrane region residues impact on sensitivity to HIV-1 Vpu.
###end title 26
###begin p 27
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 137 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 282 287 <span type="species:ncbi:9606">human</span>
###xml 558 563 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 648 653 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Co-expression of HIV-1 plasmids alone (C) with wild-type human tetherin (WT) and measurement of HIV-1 release in the absence of HIV-1 Vpu (white bar) or presence (black bar). Mutation of positively selected residues I26V, V30G, I36L, T45I (Quad) in the trans-membrane region of human tetherin results in reduced sensitivity to Vpu whilst maintaining similar antiviral activity. The effect of single mutations are also shown. Errors are standard error of the mean of 2 experiments. Equal amounts of tetherin plasmids were used (100 ng) (B) Measurement of HIV-1 p24 in the supernatant of transfected 293T cells by western blot (C) Measurement of HIV-1 Gag levels in extracts from transfected 293T cells. (D) Cell extract blots in C were stripped and re-probed for beta actin as a loading control.
###end p 27
###begin p 28
###xml 30 39 30 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3A</xref>
###xml 127 139 127 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3B&#8211;3D</xref>
###xml 230 239 230 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3B</xref>
###xml 341 350 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3C</xref>
###xml 423 432 420 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3D</xref>
For all of the experiments in Figure 3A we measured Gag levels by western blot in the cells and p24 levels in the supernatant (Figure 3B-3D). In each case p24 levels in the supernatant reflected the titer of the virus as plotted (Figure 3B) Furthermore, Gag expression levels were similar in the cells and unaffected by tetherin expression (Figure 3C). beta actin levels in cell lysates were measured as a loading control (Figure 3D).
###end p 28
###begin title 29
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpu expression leads to a loss of wild-type but not mutant tetherin proteins
###end title 29
###begin p 30
###xml 489 498 489 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g004">Figure 4A</xref>
###xml 502 511 502 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g003">Figure 3A</xref>
###xml 542 551 542 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g004">Figure 4B</xref>
###xml 570 579 570 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g004">Figure 4C</xref>
###xml 994 1003 994 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g004">Figure 4D</xref>
###xml 1181 1185 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Bouamr1">[18]</xref>
###xml 1187 1203 1187 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g004">Figure 4D and 4F</xref>
###xml 1283 1299 1280 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g004">Figure 4E and 4G</xref>
###xml 1441 1445 1438 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Bartee1">[19]</xref>
###xml 1644 1652 1641 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g005">Figure 5</xref>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 444 449 <span type="species:ncbi:9606">human</span>
###xml 1521 1526 <span type="species:ncbi:9606">human</span>
###xml 1752 1757 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
It is formally possible that the tetherin mutations responsible for reduced sensitivity to Vpu impacted on its expression levels. In order to control for this possibility, and in the absence of a tetherin antibody, we appended an N terminal epitope tag to the wild-type and quadruple mutant human tetherin proteins and performed an assay for tetherin function and Vpu sensitivity, as above. Surprisingly, we found that the tag slightly reduced human tetherin's antiviral activity, compare Figure 4A to Figure 3A. Assay of p24 in supernatant (Figure 4B) and cell lysate (Figure 4C) confirmed this observation. Nonetheless, we measured the expression levels of the tagged tetherin proteins by western blot, reasoning that if expression levels were changed by the four mutations then this would be evident in expression levels of the tagged proteins, despite their reduced activity. In fact, the wild-type and mutant unglycosylated proteins were expressed at similar levels in the absence of Vpu (Figure 4D). Importantly, co-transfection of Vpu led to reduction in the amount of tetherin detected, both in a cleared RIPA cell lysate supernatant and the associated pellet as described [18] (Figure 4D and 4F). beta actin was measured as a loading control in both supernatant and pellet (Figure 4E and 4G). These observations are concordant with those reported by Bartee et al who reported lower levels of tetherin protein in the presence of Vpu [19]. We obtained similar results when the experiment was carried out using the human single point mutant of tetherin T45I demonstrating that this single mutation can render tetherin insensitive to Vpu (Figure 5). These experiments suggest that the steady state level of tetherin is reduced by co-expression of HIV-1 Vpu, and that mutation at positively selected sites leads to a persistence of the tetherin protein presumably due to impaired interaction with the tetherin trans-membrane region.
###end p 30
###begin title 31
Vpu expression leads to a loss of wild-type but not a quadruple mutant tetherin protein steady state levels.
###end title 31
###begin p 32
###xml 540 541 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 141 146 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 421 426 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 449 454 <span type="species:ncbi:9606">human</span>
###xml 528 533 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 638 643 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 728 733 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Co-expression of HIV-1 plasmids and wild-type (WT) N terminally tagged human tetherin and measurement of HIV-1 release in the absence of HIV-1 Vpu (black bar), or presence (white bar). Mutation of positively selected residues I26V, V30G, I36L, T45I (DeltaTHN) in the trans-membrane region of human tetherin results in reduced sensitivity to Vpu whilst maintaining antiviral activity. The effect of co-transfection of HIV-1 plasmids and untagged human tetherin is shown for comparison (Lane C). The titre of the unrestricted HIV-1 was 107 infectious units/ml. Errors are standard error of the mean of 2 experiments. (B) Measurement of HIV-1 p24 in the supernatant of transfected 293T cells by western blot (C) Measurement of HIV-1 Gag levels in extracts from transfected 293T cells. Cell extract lysates (D) or pellets (F) were blotted for the Xpress tag to detect tetherin. Sizes of molecular weight markers are shown in kilodaltons. Blots in D (E) or F (G) were stripped and re-probed for beta actin as a loading control. Data are representative of 3 independent experiments and similar results were seen with an N terminal HA tag.
###end p 32
###begin title 33
Mutation of a single amino acid (T45I) leads to insensitivity to Vpu and persistence of tetherin protein.
###end title 33
###begin p 34
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 141 146 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
###xml 351 356 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 461 466 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 551 556 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Co-expression of HIV-1 plasmids and wild-type (WT) N terminally tagged human tetherin and measurement of HIV-1 release in the absence of HIV-1 Vpu (black bar), or presence (white bar). Mutation T45I in the trans-membrane region of human tetherin results in insensitivity to Vpu whilst maintaining antiviral activity. The titre of the unrestricted HIV-1 was 107 infectious units/ml. Errors are standard error of the mean of 2 experiments. (B) Measurement of HIV-1 p24 in the supernatant of transfected 293T cells by western blot (C) Measurement of HIV-1 Gag levels in cleared RIPA extracts from transfected 293T cells. Tetherin was detected by western blot of N-terminal Xpress tag in the cleared RIPA extract supernatants (D) and pellets (F) as shown. Sizes of molecular weight markers are shown in kilodaltons. Blots in (E) and (G) have been stripped and re-probed for beta actin as a loading control. Data are representative of 2 independent experiments.
###end p 34
###begin title 35
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpu mediated loss of tetherin is partially rescued by MG132
###end title 35
###begin p 36
###xml 324 332 324 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g006">Figure 6</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Schubert1">[20]</xref>
###xml 511 520 511 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g006">Figure 6A</xref>
###xml 797 806 797 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g006">Figure 6C</xref>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Belaidouni1">[21]</xref>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 191 196 <span type="species:ncbi:9606">human</span>
###xml 234 239 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 476 481 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Next we considered whether inhibition of the proteasome impacts on the Vpu mediated reduction of tetherin steady state levels. We co-expressed HIV-1 vectors and N-terminally tagged wild-type human tetherin, and examined the impact of HIV-1 Vpu-HA co-expression in the presence and absence of the proteasome inhibitor MG132 (Figure 6). Consistent with previous observations, MG132 lowered infectious titres, a phenomenon attributed to depletion of ubiquitin pools required for HIV-1 maturation and release [20] (Figure 6A). In addition, MG132 increased cellular levels of tetherin in the absence of Vpu, consistent with the notion that tetherin (like many other cellular proteins) is cycled within the host cell using ubiquitin dependent pathways. MG132 also significantly increased levels of Vpu (Figure 6C, compare left and right panels), consistent with previous observations [21].
###end p 36
###begin title 37
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpu-mediated loss of tetherin is partially abrogated by MG132.
###end title 37
###begin p 38
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 153 158 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 641 646 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Co-expression of HIV-1 plasmids and wild-type (WT) N terminally tagged human tetherin and measurement of HIV-1 release in the presence or absence of HIV-1 Vpu-HA co-expression and proteasome inhibitor MG132 (0.8 microM for 12 hours) as shown. Errors are standard error of the mean of 2 experiments. (B) Tetherin was detected by western blot of Xpress tag in cleared RIPA extract supernatants and pellets as shown. Sizes of molecular weight markers are shown in kilodaltons. (C) Vpu-HA was detected in sonicated RIPA extract as shown (D) Blots in B have been stripped and re-probed for beta actin as a loading control. (E) Measurement of HIV-1 p24 in the supernatant of transfected cells by western blot. Data are representative of 2 independent experiments.
###end p 38
###begin p 39
###xml 98 106 98 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g004">Figure 4</xref>
###xml 111 119 111 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g005">Figure 5</xref>
###xml 374 383 374 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g006">Figure 6B</xref>
###xml 954 957 954 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-VanDamme1">[6]</xref>
###xml 1222 1226 1222 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Hicke1">[22]</xref>
###xml 1460 1468 1460 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g001">Figure 1</xref>
###xml 1507 1515 1507 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000443-g006">Figure 6</xref>
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 343 348 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 565 570 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vpu leads to a loss in tetherin expression levels and a rescue of HIV-1 titre in the supernatant (Figure 4 and Figure 5). However, treatment with the proteasome inhibitor MG132 reversed the depletion of tetherin levels induced by Vpu. The drug reduced tetherin antagonism by Vpu although tetherin continued to partially inhibit the release of HIV-1, despite Vpu's presence (Figure 6B, compare left and right panels). This observation suggests that the proteasome is involved in Vpu mediated reduction of tetherin levels. Moreover, Vpu's ability to partially rescue HIV-1 release, despite being inhibited for tetherin degradation, suggests that it can inhibit tetherin via sequestration or mislocalisation. Indeed, Vpu has been demonstrated to reduce tetherin's cell surface expression and MG132 treatment did not completely restore it to the surface levels seen in the absence of Vpu, again suggesting sequestration or mislocalisation of tetherin by Vpu [6]. Since inhibiting the proteasome impacts on the levels of free ubiquitin it is also possible that tetherin is degraded by a proteasome independent pathway such as trafficking to lysosomes via endosomal sorting pathways, which are known to depend on ubiquitination [22]. We also note that MG132 treatment increases tetherin levels, raising the possibility of Vpu saturation. However, the fact that we still see maximal Vpu activity when the Tetherin plasmid dose is increased from 100 to 400 nanograms (Figure 1), as well as increased levels of Vpu (Figure 6), suggests that increased levels of tetherin protein are unlikely to explain the inhibition of Vpu mediated tetherin depletion by MG132 treatment.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 1036 1040 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Margottin1">[23]</xref>
###xml 1286 1290 1280 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Goffinet1">[24]</xref>
###xml 281 286 <span type="species:ncbi:9606">human</span>
###xml 331 336 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 569 574 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 708 713 <span type="species:ncbi:9606">human</span>
###xml 1108 1113 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1154 1159 <span type="species:ncbi:9606">human</span>
Here we provide evidence that the tetherin/CD317/BST-2 host restriction factor has been subject to positive selection during mammalian evolution. We hypothesised that the selected changes might impact on sensitivity to viral encoded tetherin countermeasures and in support of this human tetherin becomes largely insensitive to the HIV-1 encoded countermeasure, the Vpu protein, when it is mutated to represent the Tantalus monkey sequence at a single position (T45I). A second positively selected residue in the trans-membrane region V30 also impacts on sensitivity to HIV-1 Vpu, although less dramatically than T45I, when mutated to glycine. We also show that the single point mutant T45I is able to render human tetherin resistant to Vpu-mediated cellular depletion, and furthermore that the mechanism involves the proteasome or a ubiquitin-dependent pathway. This is consistent with the observation that Vpu recruits CD4 to the betaTrCP subunit of the SCF(betaTrCP) ubiquitin ligase complex leading to degradation via the proteasome [23]. Concordantly, Goffinet and colleagues have recently reported that HIV-1 Vpu mediates proteasomal degradation of human but not rodent tetherin proteins and that this is abrogated by inhibition of the proteasome with ALLN or clasto-lactacysteine [24].
###end p 41
###begin p 42
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-McNatt1">[25]</xref>
###xml 173 178 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 314 319 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In the final stages of preparation of this manuscript, McNatt and colleagues reported the findings of a similar study on species-specificity of tetherin's responsiveness to HIV-1 Vpu [25]. In contrast to our approach these investigators used chimeric constructs to show that the TM region conferred sensitivity to HIV-1 Vpu, before locating specific sensitivity determinants using systematic mutagenesis. Subsequent positive selection analysis was consistent with our findings concluding that tetherin has been under positive selection in primates.
###end p 42
###begin p 43
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Schrofelbauer1">[26]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Keckesova1">[27]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Ylinen1">[28]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Yap1">[29]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Virgen1">[30]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Kozak1">[31]</xref>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Bishop1">[32]</xref>
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 193 198 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The observation that a single mutation (T45I) can render tetherin largely insensitive to HIV-1 Vpu mediated degradation is reminiscent of point mutations impacting on APOBEC3G's sensitivity to HIV-1 Vif [26] as well as point mutations in either capsid [27],[28], TRIM5 [29], TRIMCyp [30], or Fv1 [31],[32], which strongly impact on sensitivity to restriction. Indeed, it appears to be a common theme of the interaction between restriction factors and viral proteins that only one or two amino acids dictate the difference between replication and restricted infection.
###end p 43
###begin p 44
###xml 412 415 412 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil1">[5]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Gottlinger1">[33]</xref>
###xml 506 509 506 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil3">[8]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Sakuma1">[11]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Bartee1">[19]</xref>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Bour1">[34]</xref>
###xml 1038 1042 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Abada1">[36]</xref>
###xml 1145 1149 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Kaletsky1">[37]</xref>
###xml 338 344 <span type="species:ncbi:10090">murine</span>
###xml 377 382 <span type="species:ncbi:9940">sheep</span>
###xml 400 411 <span type="species:ncbi:11741">visna virus</span>
###xml 754 759 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 948 953 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1054 1065 <span type="species:ncbi:205488">Ebola virus</span>
###xml 1221 1226 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In this study we have focused on the trans-membrane domain of tetherin. It seems likely that other tetherin sensitive viruses and their countermeasures may have caused selection at the positions outside of the trans-membrane domain. Vpu has been shown to facilitate the release of distantly related viruses including the gamma retrovirus murine leukaemia virus, as well as the sheep lentivirus maedi-visna virus [5],[33]. Vpu has also been shown to improve release of VLPs derived from the filovirus ebola [8] and Marburg and Lassa viruses [11]. These viruses do not appear to encode Vpu homologues and it is unclear whether they encode tetherin countermeasures. However, there is evidence that certain viruses have tetherin countermeasures unrelated to HIV-1 Vpu. For example, Kaposi's sarcoma associated herpes virus (KSHV) encodes a protein K5, known to reduce tetherin cell surface expression [19]. Moreover, some primate lentiviruses, such as HIV-2, are thought to have anti-tetherin function mediated by their envelope protein [34]-[36]. Moreover, Ebola virus glycoprotein has recently been shown to counteract tetherin antiviral activity [37]. We therefore speculate that viruses with countermeasures unrelated to HIV-1 Vpu are responsible for the positive selection of tetherin outside of the trans-membrane region.
###end p 44
###begin p 45
###xml 665 668 665 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil1">[5]</xref>
###xml 669 672 669 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil3">[8]</xref>
###xml 804 807 804 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil1">[5]</xref>
###xml 808 811 808 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil2">[7]</xref>
###xml 889 892 889 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Neil1">[5]</xref>
###xml 893 896 893 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-VanDamme1">[6]</xref>
###xml 1126 1130 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Yu1">[38]</xref>
###xml 1131 1135 1131 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Marin1">[39]</xref>
Our observations are evidence for a dynamic evolutionary arms race, as described by the Red Queen hypothesis, between tetherin and virus encoded countermeasures such as Vpu. They are strong evidence for tetherin having a critical role in innate immunity against retroviral infection throughout mammalian evolutionary history and underline the utility of seeking evidence for positive selection to reveal details of host virus interactions. The details of the antiviral mechanism of tetherin have been partially uncovered. Tetherin restricted viruses are prevented from leaving the surface of infected cells and are subsequently endocytosed in a Rab5a dependent way [5]-[8]. The restricted viruses achieve a very late stage of viral budding and can be released by proteolytic cleavage from infected cells [5],[7]. Vpu appears to counteract tetherin by sequestering it from the cell surface [5],[6] and our data support recent findings that Vpu causes tetherin degradation via the proteasome. This observation suggests that Vpu may work in the same way as Vif and act as an adapter protein that recruits tetherin to be degraded [38],[39].
###end p 45
###begin p 46
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Terwilliger1">[40]</xref>
Future work will include identification of countermeasures from other viruses, which are likely to have independent mechanisms for antagonising tetherin. The potential for translational application of these findings is substantial. Identification of inhibitors for Vpu, or indeed other virus-encoded countermeasures, could have powerful therapeutic potential. The multifunctional nature of Vpu, for example its ability to reduce CD4 surface expression [40], will presumably improve potency of Vpu inhibition. We also envisage tetherin binding drugs that protect it from multiple viral encoded counter measures and are therefore broadly active against different classes of enveloped viruses.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
Sequences and cloning
###end title 48
###begin p 49
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Altschul1">[41]</xref>
###xml 101 113 101 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 132 147 132 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 172 191 172 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca fascicularis</italic>
###xml 223 240 223 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca nemestrina</italic>
###xml 271 285 271 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 313 336 313 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlorocebus pygerythrus</italic>
###xml 434 455 434 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pongo pygmaeus abelii</italic>
###xml 477 495 477 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Callithrix jacchus</italic>
###xml 101 113 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 132 147 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 148 158 <span type="species:ncbi:9598">chimpanzee</span>
###xml 172 191 <span type="species:ncbi:9541">Macaca fascicularis</span>
###xml 223 240 <span type="species:ncbi:9545">Macaca nemestrina</span>
###xml 271 285 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 286 300 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 313 336 <span type="species:ncbi:60710">Chlorocebus pygerythrus</span>
###xml 337 350 <span type="species:ncbi:9534">vervet monkey</span>
###xml 376 385 <span type="species:ncbi:9601">orangutan</span>
###xml 434 455 <span type="species:ncbi:9601">Pongo pygmaeus abelii</span>
###xml 456 465 <span type="species:ncbi:9601">orangutan</span>
###xml 477 495 <span type="species:ncbi:9483">Callithrix jacchus</span>
###xml 513 522 <span type="species:ncbi:9601">Orangutan</span>
Primate tetherin sequences were retrieved using BLAST [41] and manually aligned. Sequences used were Homo sapiens human (NM004335), Pan troglodytes chimpanzee (XM_512491), Macaca fascicularis cynomolgus macaque (CJ479048), Macaca nemestrina pigtailed macaque (DY743778), Macaca mulatta rhesus macaque (CB554098), Chlorocebus pygerythrus vervet monkey. Tetherin sequences from orangutan and marmoset were inferred using BLAT () on the Pongo pygmaeus abelii orangutan genome and Callithrix jacchus marmoset genome. Orangutan sequence was confirmed by PCR cloning individual exons and sequencing.
###end p 49
###begin p 50
###xml 64 84 64 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlorocebus tantalus</italic>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Schaller1">[42]</xref>
###xml 216 257 216 257 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; - CGATGCGGCCGCCCACCATGGCACCTATTTTGTATG</named-content>
###xml 262 302 262 302 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; &#8211; GCCGATCTCGAGTCACAGCAGCAGAGCGCTCAAGC</named-content>
###xml 323 350 323 350 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGTCACCTAGTTTGTATTCC-3&#8242;</named-content>
###xml 359 382 359 382 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACACCTCAGGTCAGCAG-3&#8242;</named-content>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Kuhmann1">[43]</xref>
###xml 20 23 <span type="species:ncbi:9823">pig</span>
###xml 64 84 <span type="species:ncbi:60712">Chlorocebus tantalus</span>
###xml 307 310 <span type="species:ncbi:9823">pig</span>
###xml 670 673 <span type="species:ncbi:9823">pig</span>
###xml 746 751 <span type="species:ncbi:9606">Human</span>
Tantalus monkey and pig tetherin cDNAs were PCR cloned from the Chlorocebus tantalus (Tantalus monkey) CV1 cell line or the porcine cell line ST IOWA respectively, as described [42] using Tantalus monkey primers Fwd 5' - CGATGCGGCCGCCCACCATGGCACCTATTTTGTATG Rev 5' - GCCGATCTCGAGTCACAGCAGCAGAGCGCTCAAGC and pig primers Fwd 5'-ATGTCACCTAGTTTGTATTCC-3' and Rev 5'-ACACCTCAGGTCAGCAG-3' and inserted into pcDNA3.1 (Clontech). Cv1 cells are assumed to be derived from Tantalus monkey due to characteristic polymorphism in the CCR5 gene [43]. Four independent clones of each cDNA were sequenced. Tetherin sequences have accession numbers FJ345303 Tantalus monkey and FJ527910 pig. Site directed mutagenesis was performed using QuikChange (Stratagene). Human wild-type and mutant tetherin proteins were epitope tagged by cloning into the pCDNA4 vector encoding an N terminal Xpress epitope tag (Invitrogen) between the Not1 and Xho1 sites.
###end p 50
###begin title 51
Phylogenetic and selection analyses
###end title 51
###begin p 52
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Swofford1">[44]</xref>
Pairwise genetic distances between the nine primate tetherin sequences were calculated under the General Time Reversible model of nucleotide substitutions with proportion of invariable sites and gamma-distributed rate heterogeneity, using the program Paup* [44].
###end p 52
###begin p 53
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 119 121 119 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 144 145 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 143 145 143 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Yang1">[45]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-KosakovskyPond1">[46]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Pond1">[47]</xref>
Evidence for positive selection in the tetherin gene along the primate lineage was sought by comparison of synonymous (dS) and non-synonymous (dN) substitution rates using the program codeML from the PAML package [45] and the Random Effect Likelihood (REL) [46] method implemented by the Datamonkey web-based facility [47].
###end p 53
###begin p 54
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub>/d<sub>S</sub></italic>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 175 176 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub>/d<sub>S</sub></italic>
An excess of non-synonymous substitutions compared to synonymous substitutions (i.e. dN/dS>1) is thought to be indicative of positive (or diversifying) selection, whereas dN/dS<1 suggests negative (or purifying) selection.
###end p 54
###begin p 55
###xml 174 175 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 177 178 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 176 178 176 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 289 290 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 288 290 288 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 291 293 291 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 360 362 360 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 364 365 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 363 365 363 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
In codeML, the sequence alignment and a corresponding neighbor-joining phylogeny were successively submitted to a model in which sites are distributed into categories where dN/dS is beta-distributed between 0 and 1 (M7) and to a model in which sites are distributed into categories where dN/dS is beta-distributed between 0 and 1, with an extra category where dN/dS is freely estimated (M8). A significant better fit of M8 than M7, as indicated by a likelihood ratio test with 2 degrees of freedom, was taken as an evidence of positive selection.
###end p 55
###begin p 56
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Muse1">[48]</xref>
###xml 316 317 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 315 317 315 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 323 324 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 322 324 322 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 376 378 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 380 381 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 379 381 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 427 428 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 426 428 426 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 430 431 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 429 431 429 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 538 539 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 537 539 537 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>N</sub></italic>
###xml 541 542 541 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 540 542 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
The REL algorithm was used to identify potential codon positions evolving under positive selection. After estimating branch lengths and substitution rates under the Hasegawa-Kishino-Yano (HKY85) model of evolution, the MG94xHKY85 codon model [48] was fitted to the data to obtain independent rate distributions for dN and dS. For each codon, Bayes Factors for the events that dN<dS (indicative of negative selection) and that dN>dS (indicative of positive selection) at that site were estimated. A Bayes Factor of 20 or more in favor of dN>dS was considered strong support for adaptive selection at that site.
###end p 56
###begin title 57
Viral infection assays
###end title 57
###begin p 58
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Besnier1">[49]</xref>
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 189 196 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag-pol</italic>
###xml 230 234 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Zufferey1">[50]</xref>
###xml 312 316 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Naldini1">[51]</xref>
###xml 356 360 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Bainbridge1">[52]</xref>
###xml 584 588 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Besnier1">[49]</xref>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 321 326 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 440 445 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Preparation of VSV-G pseudotyped, YFP encoding HIV-1 has been described [49]. Briefly 106 293T cells per well were cotransfected in six well plates using 6 microl Fugene-6 (Roche) with the gag-pol expression vector p8.91 (250 ng) [50], pMDG encoding the Vesticular Stomatis Virus G glycoprotein (VSV-G) (250 ng) [51] and HIV-1 vector encoding YFP (375 ng) [52]. 100 ng of tetherin constructs were co-transfected along with either 200 ng of HIV-1 Vpu or empty vector (pCDNA3.1, Invitrogen). After 48 hours the supernatant was harvested, filtered and titered on 293T cells as described [49].
###end p 58
###begin title 59
Western blots
###end title 59
###begin p 60
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Bouamr1">[18]</xref>
###xml 536 540 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000443-Bouamr1">[18]</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 95 100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 580 585 <span type="species:ncbi:10090">mouse</span>
###xml 655 660 <span type="species:ncbi:10090">mouse</span>
HIV-1 p24 was measured in supernatants or cell pellets by western blot as described [18] using HIV-1 p24 monoclonal antibody (183-H12-5C), a gift from the NIH AIDS Research and Reference Reagent Programme. Membranes were then stripped and reprobed for beta actin as a loading control. Tetherin extracts were made by lysing cells in RIPA buffer. Cleared lysate was added to laemmli buffer and the pellet was solubilised in laemmli buffer by sonication. Samples were then boiled before separation by SDS PAGE, all as previously described [18]. Xpress epitope tag was detected using mouse anti-Xpress antibody (Invitrogen). HA epitope tag was detected using mouse anti-HA antibody (Covance).
###end p 60
###begin p 61
###xml 214 227 <span type="species:ncbi:9534">vervet monkey</span>
We thank Sergei Kosakovsky Pond, Yasu Takeuchi, and Fadila Bouamr for advice; Paul Bieniasz, Mary Collins, David Escors, Stuart Neil, Adrian Thrasher, and Didier Trono for reagents; and Stuart Neil for sharing the vervet monkey tetherin sequence.
###end p 61
###begin title 62
References
###end title 62
###begin article-title 63
###xml 70 81 <span type="species:ncbi:9598">chimpanzees</span>
Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon.
###end article-title 63
###begin article-title 64
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
###end article-title 64
###begin article-title 65
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
###end article-title 65
###begin article-title 66
Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.
###end article-title 66
###begin article-title 67
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
###end article-title 67
###begin article-title 68
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein.
###end article-title 68
###begin article-title 69
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.
###end article-title 69
###begin article-title 70
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 67 78 <span type="species:ncbi:205488">Ebola virus</span>
###xml 123 128 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.
###end article-title 70
###begin article-title 71
Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology.
###end article-title 71
###begin article-title 72
Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells.
###end article-title 72
###begin article-title 73
Inhibition of Lassa and Marburg virus production by tetherin.
###end article-title 73
###begin article-title 74
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel gene of HIV-1, vpu, and its 16-kilodalton product.
###end article-title 74
###begin article-title 75
A new evolutonary law.
###end article-title 75
###begin article-title 76
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
###end article-title 76
###begin article-title 77
Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain.
###end article-title 77
###begin article-title 78
Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha.
###end article-title 78
###begin article-title 79
###xml 0 14 <span type="species:ncbi:9544">Rhesus macaque</span>
Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities.
###end article-title 79
###begin article-title 80
###xml 84 119 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production.
###end article-title 80
###begin article-title 81
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
###end article-title 81
###begin article-title 82
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 103 108 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.
###end article-title 82
###begin article-title 83
###xml 71 76 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Involvement of the betaTrCP in the ubiquitination and stability of the HIV-1 Vpu protein.
###end article-title 83
###begin article-title 84
Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins.
###end article-title 84
###begin article-title 85
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.
###end article-title 85
###begin article-title 86
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor.
###end article-title 86
###begin article-title 87
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.
###end article-title 87
###begin article-title 88
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
###end article-title 88
###begin article-title 89
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 14 34 <span type="species:ncbi:9534">African green monkey</span>
The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
###end article-title 89
###begin article-title 90
###xml 28 33 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Differential restriction of HIV-2 and SIVmac by TRIM5alpha alleles.
###end article-title 90
###begin article-title 91
###xml 49 54 <span type="species:ncbi:9606">Human</span>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A Single Amino Acid Change in the SPRY Domain of Human Trim5alpha Leads to HIV-1 Restriction.
###end article-title 91
###begin article-title 92
Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species.
###end article-title 92
###begin article-title 93
###xml 33 54 <span type="species:ncbi:11786">murine leukemia virus</span>
Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
###end article-title 93
###begin article-title 94
###xml 51 72 <span type="species:ncbi:11786">murine leukemia virus</span>
Identification of the regions of fv1 necessary for murine leukemia virus restriction.
###end article-title 94
###begin article-title 95
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses.
###end article-title 95
###begin article-title 96
###xml 52 57 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release.
###end article-title 96
###begin article-title 97
###xml 4 32 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 93 96 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
###end article-title 97
###begin article-title 98
###xml 30 65 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.
###end article-title 98
###begin article-title 99
Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
###end article-title 99
###begin article-title 100
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
###end article-title 101
###begin article-title 102
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Functional role of human immunodeficiency virus type 1 vpu.
###end article-title 102
###begin article-title 103
Basic local alignment search tool.
###end article-title 103
###begin article-title 104
###xml 19 26 <span type="species:ncbi:9986">rabbits</span>
An active TRIM5 in rabbits indicates an antiviral common ancestor for mammalian TRIM5 proteins.
###end article-title 104
###begin article-title 105
###xml 39 59 <span type="species:ncbi:9534">African green monkey</span>
###xml 109 145 <span type="species:ncbi:11726">simian immunodeficiency virus SIVagm</span>
Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution.
###end article-title 105
###begin article-title 106
PAML: a program package for phylogenetic analysis by maximum likelihood.
###end article-title 106
###begin article-title 107
Not so different after all: a comparison of methods for detecting amino acid sites under selection.
###end article-title 107
###begin article-title 108
Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.
###end article-title 108
###begin article-title 109
A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome.
###end article-title 109
###begin article-title 110
Restriction of lentivirus in monkeys.
###end article-title 110
###begin article-title 111
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.
###end article-title 111
###begin article-title 112
In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector.
###end article-title 112
###begin article-title 113
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium.
###end article-title 113
###begin article-title 114
The PSIPRED protein structure prediction server.
###end article-title 114
###begin p 115
The authors have declared that no competing interests exist.
###end p 115
###begin p 116
This study was funded by Wellcome Trust fellowships to RG (WT081772MA) and GJT (WT076608), the Medical Research Council, the European Union, and the National Institute for Health Research UCL/UCL Hospital Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 116

